[1]
F. Ahmadabadi, “The Efficacy of Addition of Atomoxetine to Speech Therapy on the Stuttering Severity of Children Aged 4-12 Years; a Double-Blind Controlled Randomized Clinical Trial”, Iran J Child Neurol, vol. 16, no. 3, pp. 47–56, Jul. 2022.